HOLMDEL, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. BKYI, an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q3 2024 investor call Friday, November 15th at 10 a.m. ET. Results will be released after the market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session.
Conference Details
Date / Time: Friday, November 15th at 10 a.m. ETCall Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay: Webcast & Replay Link - Available for 3 months.Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 7307131
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 40 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
Engage with BIO-keyFacebook - Corporate: https://www.facebook.com/BIOkeyInternational/LinkedIn - Corporate: https://www.linkedin.com/company/bio-key-internationalX - Corporate: @BIOkeyIntlX - Investors: @BIO_keyIRStockTwits: BIO_keyIR
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
Market News and Data brought to you by Benzinga APIs